Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients	DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, viral infectious disease	Active, not recruiting	Phase 2	2026-09-24		NCT06066957

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Merck Sharp & Dohme LLC	650
University of Pennsylvania	502

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Penn Medicine at the University of Pennsylvania	Philadelphia	United States	1

Clinical trials